The diagnosis and treatment of peripheral lymphedema. Consensus document of the International Society of Lymphology.
The diagnosis and treatment of peripheral lymphedema. Consensus document of the International Society of Lymphology.
复制标题
外周淋巴水肿的诊断和治疗。
作者：
Maria Cecilia Rodriguez Hortal;L. Hjelte
本国际淋巴学学会（ISL）共识文件是1995年外周性水肿评价和管理文件的当前修订版。它基于1997年在西班牙马德里举行的第十六届国际淋巴学大会（ICL）之后建议和发表的修改，在印度钦奈举行的1999年第十七届国际淋巴学大会上讨论，在德国Hinterzarten举行的2000年（ISL）执行委员会会议上审议，并从2001年热那亚第十八届国际淋巴学大会期间和之后获得的讨论和书面意见的整合中得出，意大利，2003年在阿根廷科尔多瓦举行的ISL执行委员会会议上作了修改。该文件试图将全世界倡导的诊断和治疗周围性水肿的广泛协议合并为一项代表国际社会“共识”的协调宣言。这份文件并不意味着要凌驾于有问题的病人的个人临床考虑之上，也不意味着要扼杀进展。它也不意味着是一个法律的公式，从其中的变化定义医疗事故。本协会了解到，在一些诊所，治疗方法来自国家标准，而在其他诊所，获得医疗设备和用品的机会有限，因此建议的治疗是不切实际的。我们继续努力使文件保持简洁，同时平衡对深度和细节的需求。考虑到这些因素，我们认为该版本的共识代表了ISL成员关于如何处理2003年周围性水肿患者的最佳判断。我们预计，该文件将受到挑战，在淋巴学（例如，作为给编辑的信），并理想地成为在淋巴学和相关学科的地方，国家和国际会议上进行强有力讨论的持续焦点。我们还预计，随着经验的发展和新的想法和技术的出现，这份“活文件”将定期得到修订和完善。
This International Society of Lymphology (ISL) Consensus Document is the current revision of the 1995 Document for the evaluation and management of peripheral lymphedema. It is based upon modifications suggested and published following the 1997 XVI International Congress of Lymphology (ICL) in Madrid, Spain, discussed at the 1999 XVII ICL in Chennai, India, considered at the 2000 (ISL) Executive Committee meeting in Hinterzarten, Germany, and derived from integration of discussions and written comments obtained during and following the 2001 XVIII ICL in Genoa, Italy as modified at the 2003 ISL Executive Committee meeting in Cordoba, Argentina. The document attempts to amalgamate the broad spectrum of protocols advocated worldwide for the diagnosis and treatment of peripheral lymphedema into a coordinated proclamation representing a "Consensus" of the international community. The document is not meant to override individual clinical considerations for problematic patients nor to stifle progress. It is also not meant to be a legal formulation from which variations define medical malpractice. The Society understands that in some clinics the method of treatment derives from national standards while in others access to medical equipment and supplies is limited and therefore the suggested treatments are impractical. We continue to struggle to keep the document concise while balancing the need for depth and details. With these considerations in mind, we believe that this version of the Consensus represents the best judgment of the ISL membership on how to approach patients with peripheral lymphedema as of 2003. We anticipate that the document will and should be challenged, debated in the pages of Lymphology (e.g., as Letters to the Editor), and ideally become a continued focal point for robust discussion at local, national and international conferences in lymphology and related disciplines. We further anticipate as experience evolves and new ideas and technologies emerge that this "living document" will undergo periodic revision and refinement.